Project Grant K01DK144643
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Trustees of Indiana University (Indiana University Indianapolis) $743,458 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program on August 10, 2026. The award funds research investigating the role of the SWI/SNF chromatin remodeling complex in adipocyte expansion and its effects on systemic energy and glucose metabolism. The research uses complementary in vitro and in vivo models to elucidate the...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Indiana University Indianapolis $179,551 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to optimize the delivery of obesity treatment through facilitated assessment and selection strategies. The recipient will assess patterns and predictors of individual, combined, and sequential obesity treatment utilization in a statewide cohort; examine patient-,...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $480,697 to the Trustees of Indiana University (Indiana University Indianapolis) on March 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research investigates the role of SESTRIN3 protein in protecting against metabolic dysfunction-associated steatohepatitis (MASH)-related liver fibrosis. The project will characterize SESTRIN3 function and elucidate the...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $237,750 Project Grant to the Trustees of Indiana University (Indiana University Indianapolis) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period September 15, 2025 through August 31, 2027. The award supports a rigorous qualitative research study examining nephrology practices' participation decisions and care model reforms...
- Federal Grant Award Summary Indiana University Indianapolis received a $234,287 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 15, 2025, with completion targeted for August 31, 2027. This award funds research to investigate the social and environmental determinants of vitamin D deficiency in pediatric chronic kidney disease (CKD)...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $763,766 to Trustees of Indiana University (Indiana University Indianapolis) on August 10, 2026, for Project Grant R01DK149554 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds research investigating the role of autophagy dysfunction in type 1 diabetes onset and progression. The project will examine how impaired autophagy in beta cells promotes autoimmune...
- The National Institute of Diabetes and Digestive and Kidney Diseases, part of the Department of Health and Human Services National Institutes of Health, awarded $592,746 to Indiana University Indianapolis on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on glucose metabolism and skeletal muscle growth. The research will identify glucose transporters activated by mechanical loading in skeletal muscle, determine...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Indiana University Indianapolis $1,391,076 on August 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate barriers to timely pediatric kidney transplantation listing. The project, titled "Dissecting Missed Pediatric Priority in Kidney Transplant," examines why approximately 24 percent of children on dialysis fail to obtain priority listing before...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Trustees of Indiana University $346,000 on June 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop a video-based bundle to improve screening colonoscopy quality in lower-volume clinicians. The project addresses quality variability among lower-volume colonoscopists—predominantly surgeons in rural and peri-urban communities—who perform most U.S. colonoscopies...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Indiana University Indianapolis (Trustees of Indiana University) $104,433 on January 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the interaction between parathyroid hormone and muscle-derived irisin in chronic kidney disease–mineral bone disorder. The research examines mechanisms by which elevated parathyroid hormone in kidney disease patients...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded the Trustees of Indiana University (Indiana University Indianapolis) $158,036 in a Project Grant on August 17, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds development and pilot testing of four weight stigma reduction intervention components for adolescent-serving clinics, informed by lived experiences of patients and clinical leadership input. The interventions include protocols ensuring appropriately sized medical equipment (such as blood pressure cuffs), protocols for respectful and confidential patient weighing, revision of patient-facing materials to eliminate weight-stigmatizing messages and images, and weight stigma training for all clinical staff. The research addresses the finding that healthcare visits are sources of weight stigma for adolescents, despite published weight stigma reduction recommendations endorsed by 69 scientific and patient societies—recommendations not developed to meet adolescent-specific needs. The work will gather data for a future implementation-effectiveness trial designed to reduce systems-level weight stigma in clinics serving higher-weight adolescents, where experiencing weight stigma is associated with disordered eating behaviors, body dissatisfaction, substance use, self-harm, low self-esteem, depressive symptoms, and social isolation. Performance of work is in Indianapolis, Indiana. The period of performance extends from the award date through May 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $158.0k | 8/17/26 |